Neonatal Abstinence Syndrome: Therapeutic Interventions.
Neonatal Abstinence Syndrome: Therapeutic Interventions.
Filed under: Methadone Clinics
MCN Am J Matern Child Nurs. 2012 Nov 22;
Sublett J
ABSTRACT: Neonatal Abstinence Syndrome (NAS) occurs in infants exposed to opiates or illicit drugs during pregnancy. It can be severe and cause long hospital stays after birth and with symptoms up to 6 months after birth. Pharmacologic interventions are commonly used as treatment for NAS; however, their safety and efficacy are not fully recognized. Pharmacologic treatments for NAS include medications such as methadone, buprenorphine, morphine, and phenobarbital. Nonpharmacologic interventions and complementary therapies have been documented in neonates. However, there are gaps in literature regarding these therapies in neonatal withdrawal. This article provides an overview of the possible risks, benefits, and outcomes of pharmacologic and complementary therapies in the neonatal population and illustrates the gaps in their use for neonatal withdrawal.
HubMed – Methadone
Related Methadone Clinics Information…